Stay updated on Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page.

Latest updates to the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAddition of Revision: v3.4.2 and the removal of the funding/operating status notice are site-wide administrative updates. They do not change the study record, its data, or the core content of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check20 days agoChange DetectedAdded a government funding status notice and updated the page revision to v3.4.1, replacing v3.4.0.SummaryDifference0.6%

- Check28 days agoChange DetectedNew glossary toggle, color-coded diff highlights (green for additions, red for deletions), and a revised revision label (v3.4.0) were added, while the previous revision (v3.3.4) and the 'No FEAR Act Data' text were removed.SummaryDifference0.8%

- Check42 days agoChange DetectedAdded a new Revision: v3.3.4 entry and removed the previous Revision: v3.3.3 entry in the version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedA new Revision: v3.3.3 entry was added, and the HHS Vulnerability Disclosure link along with Revision: v3.3.2 were removed from the footer/history.SummaryDifference0.2%

- Check85 days agoChange DetectedOnly a revision label update was made (v3.3.2 added, v3.3.1 removed) and no study information or page features were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page.